Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.4.2.8 (
hypoxanthine-guanine phosphoribosyltransferase
)
2,527
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
1. Immunological quantitation of the
HPRT
proteins, together with DNA and RNA studies have defined further the heterogeneous nature of
HPRT
-deficiency in our patients. 2. These studies have dictated possible approaches for further characterisation of the
HPRT
enzyme in our patients. In the two
Lesch-Nyhan
patients, both the protein and the usual cDNA approach would appear difficult. 3. A BamHI polymorphism has been detected in Patient A. 4. Sequence data confirmed the creation of this BamHI site by a single C----T transition at position 602 in the coding sequence. 5. Sequencing of other patients is proceeding and use is being made of the Polymerase Chain Reaction (PCR)10 for amplification of specific segments of
HPRT
coding sequence.
...
PMID:Characterization of genomic DNA, mRNA and enzyme protein in cases of HPRT-deficiency. 257 80
A method for the quantitation of metabolic cooperation between cells is described. The method depends upon measuring the increase in
HGPRTase
activity that occurs between HGPRT+ cells and the HGPRT-LN (
Lesch-Nyhan
) cells. The variables upon which this method depends and their effect on the final determination are discussed.
...
PMID:Quantitation of metabolic cooperation by measurement of HGPRTase activity. 257 5
The feasibility of using RNA synthesis in freshly isolated, human peripheral blood lymphocytes to detect 6-thioguanine (TG)- and 8-azaguanine (AG)-resistant variants in an autoradiographic assay similar to that of Strauss and Albertini (1979) has been evaluated. In phytohemagglutinin (PHA)-stimulated cultures RNA synthesis and
HPRT
activity began well in advance of DNA synthesis and increased in parallel during the first 44 h of culture. Introduction of TG or AG with PHA at the beginning of culture completely inhibited DNA synthesis during the first 44 h and reduced RNA synthesis to low levels within 24 h. When TG or AG was added after cells had been in culture for 38 h, DNA synthesis was reduced quickly while RNA synthesis was inhibited more slowly. An autoradiographic assay is described in which freshly isolated lymphocytes are cultured with PHA for 24 h, with or without TG or AG, then labeled with [3H]uridine for 1 h. TG-resistant and AG-resistant variant frequencies for 2 normal individuals and a
Lesch-Nyhan
individual were determined with this assay. The variant frequencies for the normal individuals ranged from 0.46 to 10.6 X 10(-5) depending upon the selective conditions used. All the
Lesch-Nyhan
cells were resistant to 0.2 microM-2 mM AG; some were sensitive to 0.2 mM TG and most were sensitive to 2.0 mM TG.
...
PMID:Autoradiographic detection of HPRT variants of human lymphocytes resistant to RNA synthesis inhibition. 257 32
We have cloned and sequenced a full length cDNA for
HPRT
cDNA for HPRTYale isolated from
Lesch-Nyhan
subject and identified a single nucleotide substitution which results in amino acid substitution of glycine to arginine. Since most
HPRT
mutants have normal levels of specific
HPRT
messenger RNA, mutant cDNA analysis is the method of choice to define the mutation in
HPRT
deficient subjects.
...
PMID:Lesch-Nyhan syndrome due to a single nucleotide change in the hypoxanthine-guanine phosphoribosyltransferase gene (HPRTYale). 262 82
Dopaminergic mechanisms involved in self-inflicting biting behavior (SBB) were investigated in two animal models: monkeys with unilateral ventromedial tegmental (VMT) lesions of the brainstem and rats with unilateral 6-hydroxydopamine (6-OHDA) lesions of the nigrostriatal dopamine (DA) neurons. The administration of mixed D1/D2 DA agonists to some monkeys with unilateral VMT lesions of the brainstem elicits SBB of the forelimb digits contralateral to the lesion and spasticity of the contralateral hindlimb. This behavior is prevented by pretreatment with the selective D1 antagonist SCH 23390 and with the D1/D2 antagonist fluphenazine. The combined administration of the D1 DA agonist SKF 38393 with the D2 DA agonist quinpirole produces SBB at doses that were ineffective when these drugs were administered individually. The intrastriatal (middle ventrolateral area [MVL]) microinjection of the D1/D2 DA agonist apomorphine (Apo) to rats with unilateral 6-OHDA lesions elicits SBB. This behavior is not prevented by systemic administration of SCH 23390 and partially prevented by the selective D2 antagonist raclopride. However, the combined administration of SCH 23390 and raclopride completely prevents the Apo-induced SBB. Thus, the pharmacological characteristics of the DA agonist-induced SBB in monkeys with unilateral VMT lesions of the brainstem seem to differ from those induced by intrastriatal (MVL area) administration of DA agonists into rats with 6-OHDA lesions of the nigrostriatal DA neurons. The role of DA neuronal systems in the expression of SBB in
Lesch-Nyhan syndrome
and in some patients with mental retardation, as well as the link between
hypoxanthine-guanine phosphoribosyltransferase
(
HPRT
) deficiency and abnormal dopaminergic function in
Lesch-Nyhan syndrome
, is discussed.
...
PMID:Dopaminergic mechanisms in self-inflicting biting behavior. 269 8
We report the identification of a female patient with the X-linked recessive
Lesch-Nyhan syndrome
(
hypoxanthine phosphoribosyltransferase
[
HPRT
] deficiency). Cytogenetic and carrier studies revealed structurally normal chromosomes for this patient and her parents and demonstrated that this mutation arose through a de novo gametic event. Comparison of this patient's DNA with the DNA of her parents revealed that a microdeletion, which occurred within a maternal gamete and involved the entire
HPRT
gene, was partially responsible for the disease in this patient. Somatic cell hybrids, generated to separate maternal and paternal X chromosomes, showed that expression of two additional X-linked enzymes, phosphoglycerate kinase and glucose-6-phosphate dehydrogenase, were expressed only in cells that contained the maternal X chromosome, suggesting the presence of a functionally inactive paternal X chromosome. Furthermore, comparison of methylation patterns within a region of the
HPRT
gene known to be important in gene regulation revealed differences between DNA from the father and the patient, in keeping with an active
HPRT
locus in the father and an inactive
HPRT
locus in the patient. Together these data indicate that nonrandom inactivation of the cytogenetically normal paternal X chromosome and a microdeletion of the
HPRT
gene on an active maternal X chromosome were responsible for the absence of
HPRT
in this patient.
...
PMID:Molecular analysis of a female Lesch-Nyhan patient. 276 Feb 9
Our experience with the prenatal detection of the
Lesch-Nyhan syndrome
(
LNS
;
hypoxanthine-guanine phosphoribosyltransferase (HGPRT) deficiency
) in three fetuses at risk is reported. Enzyme activities were measured in cultured amniocytes in two pregnancies, and in tissues and cultures obtained from chorionic villus sampling (CVS) in a third pregnancy. In all tissues the specific activities of
HGPRT
and adenine phosphoribosyltransferase (APRT) were determined and APRT/
HGPRT
ratios were calculated. In addition to the enzyme assays, the rate of purine synthesis de novo was assessed in the two amniocyte cultures, and the rate of [14C]hypoxanthine incorporation into nucleotides and sensitivity to azaguanine were measured in one of the amniocyte cultures. We report the diagnosis of normal fetuses by study of amniocytes in two pregnancies and of
LNS
using CVS in one pregnancy. In all three cases the diagnosis was confirmed.
...
PMID:Prenatal diagnosis of Lesch-Nyhan syndrome: experience with three fetuses at risk. 279 51
The virtually complete deficiency of the purine salvage enzyme
hypoxanthine-guanine phosphoribosyltransferase
(
HPRT
) results in a devastating neurological disease,
Lesch-Nyhan syndrome
. Transfer of the
HPRT
gene into fibroblasts and lymphoblasts in vitro and into hematopoietic cells in vivo has been accomplished by other groups with retroviral-derived vectors. It appears to be necessary, however, to transfer the
HPRT
gene into neuronal cells to correct the neurological dysfunction of this disorder. The neurotropic virus herpes simplex virus type 1 has features that make it suitable for use as a vector to transfer the
HPRT
gene into neuronal tissue. This report describes the isolation of an
HPRT
-deficient rat neuroma cell line, designated B103-4C, and the construction of a recombinant herpes simplex virus type 1 that contained human
HPRT
cDNA. These recombinant viruses were used to infect B103-4C cells. Infected cells expressed
HPRT
activity which was human in origin.
...
PMID:Herpes simplex virus-mediated human hypoxanthine-guanine phosphoribosyltransferase gene transfer into neuronal cells. 282 6
Molecular analysis of an unusual patient with the
Lesch-Nyhan syndrome
has suggested that the mutation is due to a partial
HPRT
gene duplication. We now report the cloning and sequencing of the mutant
HPRT
cDNA which shows the precise duplication of exons 2 and 3. This mutation is the result of an internal duplication of 16-20 kilobases of the gene. The structure of the mutant gene suggests that the duplication was not generated by a single unequal crossing-over event between two normal
HPRT
alleles. Growth of Epstein-Barr virus-transformed lymphoblasts from this patient in selective medium has permitted isolation of spontaneous HPRT+ revertants of this mutation. The reversion event involves a second major
HPRT
gene rearrangement where most or all of the duplicated portion of the mutant gene is deleted. The original mutation therefore has the potential for spontaneous somatic reversion. This may explain the relatively mild symptoms of the
Lesch-Nyhan syndrome
exhibited by this patient.
...
PMID:Spontaneous reversion of novel Lesch-Nyhan mutation by HPRT gene rearrangement. 283 25
The metabolic pathways of pterin de novo synthesis, interconversion and salvage which lead to the tetrahydrobiopterin cofactor of phenylalanine 4-monooxygenase, tyrosine 2-monooxygenase and tryptophan 5-monooxygenase are reviewed and data on the enzymes which catalyze the individual steps are presented. Analogies drawn between the inborn errors of tetrahydrobiopterin production and the
Lesch-Nyhan syndrome
, in which purine salvage is deficient, are used as a basis for the hypothesis that the neurological manifestations of the
Lesch-Nyhan syndrome
are due to neurotransmitter imbalance which stems from an imbalance of the aromatic amino acid monooxygenase activities which are themselves due to impaired pterin biosynthesis. The latter arises because, in the absence of the
hypoxanthine phosphoribosyltransferase
catalyzed purine salvage pathway, the supply of GTP for the GTP cyclohydrolase reaction, which is the first reaction on the pterin de novo synthesis pathway, is reduced. It is proposed that the different aromatic amino acid monooxygenases are differentially affected by this constrained pterin production. The activities of those most directly related to the quantal production of the cerebral neurotransmitters dopamine, norepinephrine and 5-hydroxytryptamine are affected whereas liver phenylalanine 4-monooxygenase activity is not overtly impaired. The results of different lines of research which support this concept are cited, as is direct evidence for a selective reduction of dopamine production in the basal ganglia of patients with the
Lesch-Nyhan syndrome
. It is proposed that lack of GMP for functions, other than its role in pterin de novo synthesis, accounts for the features of the
Lesch-Nyhan syndrome
which do not occur when only tetrahydrobiopterin production is deficient as in the inborn errors of tetrahydrobiopterin synthesis.
...
PMID:Defects of tetrahydrobiopterin synthesis and their possible relationship to a disorder of purine metabolism (the Lesch-Nyhan syndrome). 286 76
<< Previous
1
2
3
4
5
6
7
8
9
10
Next >>